CBR1 Recombinant Antibody, PE-Cy7 Conjugated
Referência bsm-61367R-PE-Cy7
Tamanho : 100uL
Marca : Bioss
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61367r-pe-cy7 |
| Product Name | CBR1 Recombinant Antibody, PE-Cy7 Conjugated |
| Applications | WB |
| Reactivity | Human |
| Specifications | |
| Conjugation | PE-Cy7 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human CBR1 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 873 |
| Swiss Prot | P16152 |
| Subcellular location | Cytoplasm |
| Synonyms | 15 hydroxyprostaglandin dehydrogenase [NADP+]; Carbonyl reductase [NADPH] 1; CBR1; CRN; NADPH dependent carbonyl reductase 1; Prostaglandin 9 ketoreductase; SDR21C1. |
| Background | NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. |
| Application Dilution | |
| WB | 1:500-2000 |